Philip Suh, MD
General Practice · Honolulu, HINPI 1518934009
Payments from drug & device makers
Across 2,956 payments — averaging $101.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$102K
- Novo Nordisk$33K
- AstraZeneca$32K
- Amarin Pharma, Inc.$30K
- AbbVie$26K
- Johnson & Johnson$24K
- plus $52K from 47 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$298,878 in reported general payments places this provider in the 95th percentile of 650 general practice providers in Hawaii.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other general practice in Honolulu
- Kent HironakaHonolulu$94K
- Jason AkoHonolulu$81K
- Wynn OkudaHonolulu$60K
- Russell TacataHonolulu$22K
- Eugene AzumaHonolulu$14K
- Blake KitamuraHonolulu$11K
- Lance TeramotoHonolulu$8K
- Kyrell WrightHonolulu$7K
- Ann HashitateHonolulu$7K
- William SiciliaHonolulu$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.